SPAC31G5.19 Antibody

What is SPAC31G5.19 and what cellular functions has it been associated with?

SPAC31G5.19 is an uncharacterized AAA domain-containing protein found in Schizosaccharomyces pombe (fission yeast). It has been identified as having potential roles in chromatin silencing at centromeres through systematic genetic screening. The protein contains an AAA (ATPases Associated with diverse cellular Activities) domain, suggesting possible involvement in energy-dependent protein unfolding or disassembly of protein complexes. Recent research has implicated this protein in heterochromatin integrity maintenance, particularly at centromeric regions . The protein has also shown interactions with splicing factors, suggesting potential involvement in RNA processing pathways or related chromatin functions .

What antibody formats are available for detecting SPAC31G5.19?

Currently, the main antibody format available for SPAC31G5.19 detection is polyclonal antibody raised in rabbits against Schizosaccharomyces pombe strain 972/24843. These antibodies are typically purified through antigen-affinity methods to ensure specificity . The antibodies are of IgG isotype and are validated for applications including ELISA and Western Blot analysis to ensure proper identification of the target antigen .

What is the typical reactivity profile of SPAC31G5.19 antibodies?

SPAC31G5.19 antibodies show specific reactivity against Schizosaccharomyces pombe strain 972/24843 (fission yeast) proteins. The commercially available rabbit polyclonal antibodies demonstrate high specificity when used for Western blot and ELISA applications . Cross-reactivity with homologous proteins in other yeast species has not been extensively documented, and researchers should validate antibody specificity when working with non-S. pombe samples.

How can SPAC31G5.19 antibodies be effectively used in chromatin immunoprecipitation (ChIP) experiments?

For optimal ChIP experiments using SPAC31G5.19 antibodies, researchers should follow these methodological considerations:

• Crosslinking optimization: Use 1% formaldehyde for 10-15 minutes at room temperature for S. pombe cells.

• Sonication parameters: Adjust to achieve chromatin fragments of 200-500bp.

• Antibody incubation: Use 2-5μg of affinity-purified SPAC31G5.19 antibody per ChIP reaction.

• Controls: Include IgG isotype control and input samples.

• Validation: Confirm enrichment at centromeric regions where SPAC31G5.19 has been shown to associate with heterochromatin.

When analyzing results, focus on centromeric regions where SPAC31G5.19 has been implicated in heterochromatin integrity. This approach can help identify genomic loci where this protein functions, particularly in relation to H3K9 methylation patterns which have shown reduction in SPAC31G5.19 mutants .

What are the recommended protocols for detecting SPAC31G5.19 in Western blot applications?

For optimal Western blot detection of SPAC31G5.19:

• Sample preparation: Extract proteins from S. pombe using glass bead disruption in lysis buffer (50mM Tris-HCl pH 7.5, 150mM NaCl, 1% NP-40, protease inhibitors).

• Gel parameters: Use 10% SDS-PAGE for optimal separation.

• Transfer conditions: Transfer to PVDF membrane at 100V for 1 hour or 30V overnight at 4°C.

• Blocking: Block with 5% non-fat milk in TBST for 1 hour at room temperature.

• Primary antibody: Dilute SPAC31G5.19 antibody 1:1000 in blocking buffer and incubate overnight at 4°C.

• Detection: Use HRP-conjugated anti-rabbit secondary antibody (1:5000) and ECL detection.

Expected band size will depend on the specific variant of SPAC31G5.19 being studied. Ensure antibody specificity by including appropriate negative controls (such as SPAC31G5.19 deletion mutants) .

How can researchers validate the specificity of SPAC31G5.19 antibodies in their experimental systems?

To validate antibody specificity:

• Genetic approach: Compare wild-type and SPAC31G5.19 deletion mutant strains in Western blot or immunofluorescence experiments. The specific signal should be absent in the deletion mutant.

• Epitope competition: Pre-incubate antibody with excess recombinant SPAC31G5.19 protein before immunostaining or Western blot. This should abolish specific signals.

• Multiple antibodies: When possible, use antibodies targeting different epitopes of SPAC31G5.19 to confirm results.

• Knockdown validation: Use RNA interference or genetic repression systems to reduce SPAC31G5.19 expression, which should correspondingly reduce antibody signals.

• Mass spectrometry: Perform immunoprecipitation followed by mass spectrometry to confirm that the antibody is capturing the intended target.

This multi-pronged validation approach ensures experimental results are attributable to SPAC31G5.19 and not to off-target effects or cross-reactivity .

How does SPAC31G5.19 contribute to centromeric heterochromatin formation in S. pombe?

Research indicates that SPAC31G5.19 plays a significant role in maintaining centromeric heterochromatin integrity in S. pombe. Systematic genetic screening has identified it as a factor whose deletion results in defective silencing of marker genes (such as cen1:ade6) inserted into centromeric regions .

Mechanistically, SPAC31G5.19 appears to be required for proper H3K9 methylation at centromeres, a key epigenetic mark of heterochromatin. Cells lacking SPAC31G5.19 show reduced levels of H3K9 methylation at centromeric regions as measured by chromatin immunoprecipitation (ChIP) . Interestingly, the function seems to be centromere-specific, as silencing at the mating-type locus remains intact in SPAC31G5.19 deletion mutants.

The protein may function in a pathway connected to RNA processing, as it shows genetic interactions with splicing factors like Cwf11, and mutants accumulate unspliced transcripts . This suggests a potential role in co-transcriptional regulation or RNA-directed heterochromatin formation.

What experimental approaches can detect SPAC31G5.19's relationship with chromatin silencing?

To investigate SPAC31G5.19's role in chromatin silencing, researchers can employ several complementary approaches:

• Silencing assays: Use reporter genes (ade6+, ura4+) inserted into heterochromatic regions. In wild-type cells, these reporters are silenced, while in SPAC31G5.19 mutants, expression increases. This can be assessed through:

  • Growth assays on selective media (e.g., -ade plates)

  • Colony color assays (red/white on limiting adenine media)

  • RT-PCR quantification of reporter transcripts

• Chromatin immunoprecipitation (ChIP): Measure H3K9 methylation levels at centromeres using:

  • ChIP-qPCR for specific centromeric regions

  • ChIP-seq for genome-wide analysis

• Genetic interaction analysis: Test for synthetic interactions between SPAC31G5.19 deletions and mutations in:

  • Known heterochromatin factors (e.g., clr4, swi6)

  • Splicing factors (e.g., cwf11, cdc5, prp1)

• RNA analysis: Measure centromeric transcript levels and splicing efficiency using:

  • RT-PCR with intron-spanning primers

  • RNA-seq to identify genome-wide splicing defects

These methodological approaches provide complementary data on SPAC31G5.19's role in heterochromatin formation and maintenance .

How do mutations in SPAC31G5.19 affect heterochromatin stability compared to other known factors?

SPAC31G5.19 mutations have distinct effects on heterochromatin stability compared to other known factors:

SPAC31G5.19 mutation phenotypes most closely resemble those of splicing-related factors (Saf1, Saf5) rather than core heterochromatin components (Clr4, Swi6). This suggests that SPAC31G5.19 functions in an RNA processing-dependent pathway for heterochromatin formation specifically at centromeres .

What high-throughput approaches can be used to study SPAC31G5.19 antibody interactions with chromatin-associated proteins?

Several high-throughput methodologies can illuminate SPAC31G5.19's interactions:

• IP-Mass Spectrometry: Immunoprecipitate SPAC31G5.19 using validated antibodies followed by mass spectrometry to identify interacting proteins. This approach can reveal both stable and transient interactions within chromatin-associated complexes.

• ChIP-seq with SPAC31G5.19 antibodies: Map genome-wide binding sites of SPAC31G5.19, particularly focusing on centromeric regions and correlation with heterochromatin marks.

• Proximity labeling techniques:

  • BioID: Fuse SPAC31G5.19 with a biotin ligase to biotinylate nearby proteins

  • APEX2: Use peroxidase-based proximity labeling
    These approaches can capture even transient interactions within the cellular context.

• Protein arrays: Test purified SPAC31G5.19 binding against arrays of recombinant chromatin-associated proteins to identify direct interactions.

• Cross-linking mass spectrometry (XL-MS): Identify specific residues involved in protein-protein interactions through chemical cross-linking followed by mass spectrometry.

These high-throughput approaches should be complemented with focused validation experiments to confirm the biological relevance of identified interactions .

How can researchers distinguish between direct and indirect effects of SPAC31G5.19 on heterochromatin formation?

Distinguishing direct from indirect effects requires multiple complementary approaches:

• Temporal analysis: Use rapidly inducible degron-tagged SPAC31G5.19 to deplete the protein acutely and monitor immediate versus delayed effects on heterochromatin marks and transcription.

• Domain mutation analysis: Generate point mutations in specific functional domains of SPAC31G5.19 (particularly the AAA domain) to separate different activities of the protein.

• In vitro reconstitution: Purify recombinant SPAC31G5.19 and test its direct biochemical activities on chromatin templates or RNA substrates.

• ChIP-reChIP: Perform sequential ChIP with antibodies against SPAC31G5.19 and known heterochromatin factors to determine if they co-occupy the same chromatin fragments.

• Genetic epistasis analysis: Combine SPAC31G5.19 mutations with mutations in factors acting in known pathways (RNAi, CLRC complex, splicing factors) to determine pathway relationships.

These approaches can help delineate whether SPAC31G5.19 directly participates in heterochromatin assembly or influences it indirectly through effects on RNA processing or other cellular processes .

What are the optimized conditions for using SPAC31G5.19 antibodies in immunofluorescence microscopy?

For optimal immunofluorescence microscopy with SPAC31G5.19 antibodies:

• Fixation protocol:

  • Fix S. pombe cells with 3.7% formaldehyde for 30 minutes at room temperature

  • Alternative: Fix with cold methanol (-20°C) for 6 minutes for enhanced nuclear protein detection

• Cell wall digestion:

  • Treat with Zymolyase 100T (1mg/ml) in PEMS buffer for 30 minutes at 37°C

  • Monitor digestion progress by observing cell wall breakdown microscopically

• Permeabilization:

  • Use 1% Triton X-100 in PBS for 5 minutes at room temperature

• Blocking conditions:

  • Block with 5% BSA, 0.1% Tween-20 in PBS for 1 hour at room temperature

• Antibody dilutions and incubation:

  • Primary: Use SPAC31G5.19 antibody at 1:200 dilution, overnight at 4°C

  • Secondary: Alexa Fluor-conjugated anti-rabbit at 1:500, 1 hour at room temperature

• Controls and counterstaining:

  • Include SPAC31G5.19 deletion strain as negative control

  • Counterstain with DAPI (1μg/ml) to visualize nuclei

  • Consider co-staining with known heterochromatin markers (H3K9me, Swi6/HP1)

• Imaging parameters:

  • Use confocal microscopy for optimal subcellular localization

  • Capture z-stacks to ensure complete nuclear visualization

This protocol should allow visualization of SPAC31G5.19's nuclear localization pattern, particularly its association with heterochromatic regions .

What are common challenges when working with SPAC31G5.19 antibodies and how can they be addressed?

Researchers commonly encounter several challenges when working with SPAC31G5.19 antibodies:

• High background in Western blots:

  • Solution: Increase blocking time/concentration (use 5% BSA instead of milk)

  • Increase washing stringency (0.1% to 0.3% Tween-20)

  • Optimize primary antibody dilution (try 1:2000 instead of 1:1000)

  • Use highly purified antibody preparations (>85% purity)

• Weak or inconsistent signals in ChIP experiments:

  • Solution: Optimize crosslinking time

  • Increase antibody amount (5-10μg per reaction)

  • Use different sonication conditions to improve chromatin fragmentation

  • Pre-clear chromatin with protein A/G beads before antibody addition

• Non-specific bands in Western blots:

  • Solution: Include competitive blocking with recombinant protein

  • Use more stringent washing conditions

  • Validate with SPAC31G5.19 deletion strain as negative control

• Poor immunoprecipitation efficiency:

  • Solution: Use a combination of protein A and protein G beads

  • Pre-conjugate antibody to beads before adding lysate

  • Optimize salt concentration in wash buffers

• Batch-to-batch antibody variation:

  • Solution: Validate each new lot against previous lots

  • Maintain consistent positive controls across experiments

  • Consider developing monoclonal antibodies for greater consistency

These troubleshooting approaches can significantly improve experimental outcomes when working with SPAC31G5.19 antibodies .

How can researchers optimize antibody-based detection of SPAC31G5.19 in different strain backgrounds or growth conditions?

Optimizing SPAC31G5.19 detection across different experimental conditions requires systematic adjustment:

• Strain background optimization:

  • Create strain-specific standard curves using recombinant protein

  • Adjust extraction buffers based on cell wall differences between strains

  • Validate antibody reactivity against each new strain background

  • Consider using epitope-tagged SPAC31G5.19 in problematic backgrounds

• Growth condition adjustments:

  • For nutrient-limited conditions: Increase cell numbers by 2-3 fold

  • For stress conditions: Optimize extraction buffers to account for stress-induced modifications

  • For temperature-sensitive experiments: Perform extractions at the experimental temperature

  • For cell cycle studies: Synchronize cultures and validate detection at different cell cycle stages

• Extraction protocol modifications:

  • Under repressive conditions: Use harsher extraction methods (e.g., TCA precipitation)

  • For membrane-associated fractions: Include detergent optimization steps

  • For nuclear extracts: Include sonication and nuclease treatment

• Antibody concentration optimization:

  • Perform titration curves for each new condition

  • Consider using signal amplification methods for low expression conditions

• Signal normalization strategies:

  • Use loading controls appropriate for the condition (some traditional controls vary with condition)

  • Consider spike-in controls for absolute quantification

These optimization strategies ensure consistent and accurate detection of SPAC31G5.19 across diverse experimental conditions .

How can high-throughput screening approaches be adapted to study SPAC31G5.19 function in heterochromatin formation?

Adapting high-throughput screening methods for SPAC31G5.19 functional studies can accelerate discovery:

• Genetic interaction screening:

  • Use synthetic genetic array (SGA) analysis to identify genetic interactions between SPAC31G5.19 and the entire S. pombe deletion collection

  • Focus on genes involved in chromatin modification, transcription, and RNA processing

  • Quantify growth phenotypes systematically using automated imaging and analysis

• Chemical-genetic profiling:

  • Screen SPAC31G5.19 mutants against chemical libraries to identify compounds that specifically affect cells lacking this protein

  • Look for compounds affecting heterochromatin stability or RNA processing

• High-content microscopy screening:

  • Create reporter systems with fluorescent markers of heterochromatin integrity

  • Screen gene deletions or chemical compounds for effects on reporter localization

  • Multiplex with markers for SPAC31G5.19 localization

• CRISPR-based functional genomics:

  • Design sgRNA libraries targeting potential interacting partners

  • Use CRISPRi/CRISPRa approaches to modulate gene expression rather than deletion

  • Combine with reporter systems for heterochromatin integrity

• Proteomic screening approaches:

  • Perform stable isotope labeling with amino acids in cell culture (SILAC) to quantify protein interaction changes under different conditions

  • Use protein arrays to identify direct binding partners

These approaches should be complemented by appropriate statistical analyses and validation experiments to confirm hits from the screens .

What are the current hypotheses about the molecular mechanism of SPAC31G5.19's role in heterochromatin assembly?

Several hypotheses have emerged regarding SPAC31G5.19's molecular mechanism in heterochromatin assembly:

• Direct chromatin remodeling hypothesis:

  • The AAA domain may provide ATP-dependent activity to remodel chromatin structure

  • SPAC31G5.19 could directly facilitate heterochromatin protein complex assembly or stability

  • Supporting evidence: Reduced H3K9 methylation in mutants

• RNA processing pathway hypothesis:

  • SPAC31G5.19 may function in processing centromeric transcripts essential for RNAi-directed heterochromatin formation

  • This could involve splicing regulation of specific transcripts involved in silencing

  • Supporting evidence: Genetic interactions with splicing factors and accumulation of unspliced transcripts in mutants

• Co-transcriptional regulation hypothesis:

  • SPAC31G5.19 might function at the interface between transcription and chromatin modification

  • It could couple RNA processing events with recruitment of silencing factors

  • Supporting evidence: Centromere-specific effects with no impact on mating-type silencing

• Heterochromatin boundary element hypothesis:

  • The protein might play a role in establishing or maintaining boundaries between heterochromatin and euchromatin

  • This function could be critical specifically at centromeric regions

  • Supporting evidence: Specific effects on centromeric silencing

Future research combining structural studies, in vitro biochemical assays, and in vivo genetic analysis will be needed to distinguish between these hypotheses and elucidate the precise mechanism .

How might molecular docking and structural prediction approaches inform antibody design for SPAC31G5.19?

Advanced computational approaches can significantly enhance antibody development for SPAC31G5.19:

• Structural prediction using AlphaFold2:

  • Generate high-confidence 3D models of SPAC31G5.19 structure

  • Identify surface-exposed epitopes most suitable for antibody recognition

  • Predict conformational changes that might affect epitope accessibility

• Epitope prediction and validation:

  • Use computational algorithms to identify immunogenic regions

  • Focus on regions with high antigenicity scores and surface accessibility

  • Validate predicted epitopes experimentally through peptide array analysis

• Molecular docking for antibody-antigen interactions:

  • Model the interaction between potential antibodies and SPAC31G5.19

  • Identify key residues involved in the binding interface

  • Optimize binding affinity through in silico mutagenesis

• Structure-guided antibody engineering:

  • Design antibodies targeting specific functional domains (e.g., the AAA domain)

  • Engineer antibodies with improved specificity and reduced cross-reactivity

  • Develop conformation-specific antibodies that distinguish between active/inactive states

• Epitope-focused libraries:

  • Create phage display libraries focused on predicted optimal binding regions

  • Screen for antibodies with desired properties (specificity, affinity)

This computational-experimental integrated approach can yield antibodies with nanomolar affinity and high specificity, similar to the approaches that have been successful for other challenging targets such as SpA5, where molecular docking identified critical epitopes .

What emerging technologies might enhance the study of SPAC31G5.19's role in chromatin regulation?

Several cutting-edge technologies show promise for advancing SPAC31G5.19 research:

• Single-cell technologies:

  • Single-cell RNA-seq to capture cell-to-cell variability in heterochromatin states

  • Single-cell ChIP-seq for heterochromatin mark distribution

  • Single-cell proteomics to quantify SPAC31G5.19 abundance across individual cells

• Live-cell imaging approaches:

  • CRISPR-based tagging for live visualization of SPAC31G5.19

  • FRAP (Fluorescence Recovery After Photobleaching) to measure dynamics

  • Single-molecule tracking to analyze SPAC31G5.19 movement within the nucleus

• Spatial transcriptomics:

  • Map the spatial relationship between SPAC31G5.19 localization and transcript processing

  • Correlate with heterochromatin domain organization

• Cryo-electron microscopy:

  • Determine high-resolution structures of SPAC31G5.19 complexes

  • Visualize interactions with chromatin and RNA processing machinery

• Genomic engineering tools:

  • Prime editing for precise modification of SPAC31G5.19 domains

  • Optogenetic control of SPAC31G5.19 function with temporal precision

  • Degron-based systems for rapid protein depletion

These technologies can provide unprecedented insights into the dynamic role of SPAC31G5.19 in chromatin regulation and help resolve current mechanistic questions .

How might comparative studies across different yeast species inform our understanding of SPAC31G5.19 function?

Comparative studies offer valuable evolutionary perspectives on SPAC31G5.19 function:

• Homolog identification and conservation analysis:

  • Identify SPAC31G5.19 homologs across diverse fungal species

  • Analyze sequence conservation patterns, particularly within the AAA domain

  • Map conserved regions to predicted functional domains

• Functional complementation experiments:

  • Test whether SPAC31G5.19 homologs from other species can rescue S. pombe deletion phenotypes

  • Identify species-specific versus conserved functions

• Heterochromatin formation comparison:

  • Compare centromeric heterochromatin assembly mechanisms across species

  • Determine if the role of SPAC31G5.19-like proteins in heterochromatin is conserved

• Domain swapping experiments:

  • Create chimeric proteins with domains from different species' homologs

  • Identify which domains are responsible for species-specific functions

• Co-evolution analysis:

  • Identify proteins that co-evolve with SPAC31G5.19 across species

  • Use this information to predict functional interactions

This evolutionary approach can reveal fundamental principles about chromatin regulation and identify both conserved mechanisms and species-specific adaptations in heterochromatin assembly .

What potential clinical or biotechnological applications might emerge from better understanding SPAC31G5.19's role in chromatin regulation?

Understanding SPAC31G5.19's function could lead to several applications:

• Epigenetic drug discovery platforms:

  • Use insights from SPAC31G5.19 mechanism to identify novel targets for epigenetic therapeutics

  • Develop screening assays for compounds affecting heterochromatin assembly

  • Focus on diseases with dysregulated heterochromatin (cancer, neurodegenerative disorders)

• Synthetic biology applications:

  • Engineer artificial heterochromatin domains with controllable properties

  • Design synthetic gene silencing systems based on SPAC31G5.19 mechanisms

  • Create biosensors for heterochromatin integrity

• Biotechnological tools:

  • Develop SPAC31G5.19-based tools for targeted gene silencing

  • Create methods for stable transgene expression by manipulating heterochromatin boundaries

  • Use SPAC31G5.19 pathways to stabilize difficult-to-maintain genomic regions

• Agricultural applications:

  • Apply knowledge to improve genome stability in crop species

  • Target homologous pathways to modulate gene expression in plants

• Diagnostic markers:

  • Develop markers for heterochromatin dysfunction in human diseases

  • Create assays measuring heterochromatin integrity in patient samples

While currently theoretical, these applications highlight the potential translational impact of basic research on chromatin regulatory mechanisms .